Brassica Genus Seeds: A Review on Phytochemical Screening and Pharmacological Properties.
Jawaher AyadiMohamed DeboubaRami RahmaniJalloul BouajilaPublished in: Molecules (Basel, Switzerland) (2022)
Traditionally, Brassica species are widely used in traditional medicine, human food, and animal feed. Recently, special attention has been dedicated to Brassica seeds as source of health-promoting phytochemicals. This review provides a summary of recent research on the Brassica seed phytochemistry, bioactivity, dietary importance, and toxicity by screening the major online scientific database sources and papers published in recent decades by Elsevier, Springer, and John Wiley. The search was conducted covering the period from January 1964 to July 2022. Phytochemically, polyphenols, glucosinolates, and their degradation products were the predominant secondary metabolites in seeds. Different extracts and their purified constituents from seeds of Brassica species have been found to possess a wide range of biological properties including antioxidant, anticancer, antimicrobial, anti-inflammatory, antidiabetic, and neuroprotective activities. These valuable functional properties of Brassica seeds are related to their richness in active compounds responsible for the prevention and treatment of various chronic diseases such as obesity, diabetes, cancer, and COVID-19. Currently, the potential properties of Brassica seeds and their components are the main focus of research, but their toxicity and health risks must also be accounted for.
Keyphrases
- genome wide identification
- genome wide analysis
- arabidopsis thaliana
- anti inflammatory
- type diabetes
- oxidative stress
- healthcare
- sars cov
- mental health
- endothelial cells
- coronavirus disease
- public health
- transcription factor
- staphylococcus aureus
- insulin resistance
- cardiovascular disease
- social media
- health information
- weight loss
- physical activity
- body mass index
- squamous cell carcinoma
- skeletal muscle
- ms ms
- papillary thyroid
- glycemic control
- adipose tissue
- cerebral ischemia
- genetic diversity